Literature DB >> 6383589

Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses.

E D Ralph.   

Abstract

Antimicrobial therapy without surgical drainage or therapeutic aspiration was effective in the management of four patients with deep abscesses ranging in diameter from 1.3 to 10.0 cm. Two of the patients had multiple hepatic abscesses, one had hepatic, intra-abdominal and intrapelvic abscesses, and one had an intrapelvic abscess alone. Anaerobic bacteria were isolated from the blood or abscesses in all four patients, and an aerobic-anaerobic infection was present in one patient. The patients were treated with metronidazole, alone or in combination with other antibiotics, for 3 to 6 weeks. Therefore, in selected patients with deep abscesses, a therapeutic trial of antimicrobial agents instead of surgery may be justified.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383589      PMCID: PMC1483613     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  13 in total

1.  Activity of combinations of antimicrobial agents against Bacteroides fragilis.

Authors:  D F Busch; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

2.  The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria.

Authors:  E D Ralph
Journal:  J Antimicrob Chemother       Date:  1978-03       Impact factor: 5.790

3.  Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis.

Authors:  A B Onderdonk; T J Louie; F P Tally; J G Bartlett
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

4.  Successful medical treatment of pyogenic liver abscess.

Authors:  J A Maher; T B Reynolds; A E Yellin
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

5.  Pyogenic liver abscesses: successful non-surgical therapy.

Authors:  D A Herbert; D A Fogel; J Rothman; S Wilson; F Simmons; J Ruskin
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

6.  Presentation, diagnosis and management of liver abscess.

Authors:  M R Perera; A Kirk; P Noone
Journal:  Lancet       Date:  1980-09-20       Impact factor: 79.321

Review 7.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

8.  Neurologic toxicity associated with high-dose metronidazole therapy.

Authors:  S Frytak; C H Moertel; D S Childs
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

9.  Metronidazole treatment of liver abscess due to bacteroides fragilis.

Authors:  E Bäck; J Hermanson; M Wickman
Journal:  Scand J Infect Dis       Date:  1978

10.  Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.

Authors:  E D Ralph; Y E Amatnieks
Journal:  Sex Transm Dis       Date:  1980 Oct-Dec       Impact factor: 2.830

View more
  2 in total

Review 1.  Percutaneous abscess and fluid drainage: a critical review.

Authors:  R E Lambiase
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

Review 2.  Fusobacterial liver abscess: a case report and review of the literature.

Authors:  Dilip Jayasimhan; Linus Wu; Paul Huggan
Journal:  BMC Infect Dis       Date:  2017-06-20       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.